Effect of Health Beliefs on Delays in Care for Abnormal Cervical Cytology in a Multi-ethnic Population

Overview

Journal J Gen Intern Med

Publisher Springer

Specialty General Medicine

Date 2002 Sep 11

PMID 12220368

Citations 29

Authors

Karin Nelson

Ann M Geiger

Carol M Mangione

Affiliations

Soon will be listed here.

Abstract

Context: Women from racial and ethnic minorities in the United States have higher rates of cervical cancer and present with later stage disease compared to whites. Delays in care for abnormal Papanicolaou (Pap) smears can lead to missed cases of cervical cancer or late-stage presentation and may be one explanation for these differences.

Objective: To determine if race and ethnicity, health beliefs, and cancer knowledge are associated with delays in care for abnormal Pap smears.

Design, Participants, And Setting: We conducted a mailed survey with telephone follow-up of all women with an abnormal Pap smear who received care at Kaiser Permanente Los Angeles Medical Center between October 1998 and October 1999 (n = 1,049).

Measurements And Main Results: A delay in care was defined as not attending the first scheduled clinic visit to follow up on an abnormal Pap smear, or requiring multiple contact attempts, including a certified letter, to schedule a follow-up visit. Our response rate was 70% (n = 733) and the sample was 51% Latina. Spanish-speaking Latinas and women of Asian descent were more likely to endorse fatalistic beliefs and misconceptions about cancer. Thirteen percent of the sample delayed follow-up on their abnormal Pap smear. Women who delayed care were more fatalistic and endorsed more misconceptions about cervical cancer. Delays in care were not independently associated with race and ethnicity.

Conclusions: Health beliefs and cancer knowledge differed by race and ethnicity among women in a large managed care organization. Fatalistic health beliefs and misconceptions about cancer, but not race and ethnicity, were independently associated with delays in care.

Citing Articles

A Proposed mHealth Intervention to Address Patient Barriers to Colposcopy Attendance: Qualitative Interview Study of Clinic Staff and Patient Perspectives.

Hemler J, Wagner R, Sullivan B, Macenat M, Tagai E, Vega J JMIR Form Res. 2025; 9:e55043.

PMID: 39808485 PMC: 11775484. DOI: 10.2196/55043.

Chatbot-interfaced and cognitive-affective barrier-driven messages to improve colposcopy adherence after abnormal Pap test results in underserved urban women: A feasibility pilot study.

Wen K, Dayaratna S, Slamon R, Granda-Cameron C, Tagai E, Kohler R Transl Behav Med. 2023; 14(1):1-12.

PMID: 38014626 PMC: 10782901. DOI: 10.1093/tbm/ibad064.

Confusion and anxiety in between abnormal cervical cancer screening results and colposcopy: "The land of the unknown".

Kohler R, Hemler J, Wagner R, Sullivan B, Macenat M, Tagai E Patient Educ Couns. 2023; 114:107810.

PMID: 37244133 PMC: 10527466. DOI: 10.1016/j.pec.2023.107810.

Unlocking infodemics and mysteries in COVID-19 vaccine hesitancy: Nexus of conspiracy beliefs, digital informational support, psychological Well-being, and religious fatalism.

Raza S, Yousaf M, Zaman U, Waheed Khan S, Core R, Malik A Vaccine. 2023; 41(10):1703-1715.

PMID: 36754765 PMC: 9894779. DOI: 10.1016/j.vaccine.2023.01.047.

Patient delay and related influencing factors in Chinese women under 35 years diagnosed with cervical cancer: A cross-sectional study.

Ma J, Luo Y, Yang S, Liu X, Peng Y, Wang H Asia Pac J Oncol Nurs. 2022; 10(2):100165.

PMID: 36579173 PMC: 9791130. DOI: 10.1016/j.apjon.2022.100165.

References

Kagawa-Singer M, Pourat N . Asian American and Pacific Islander breast and cervical carcinoma screening rates and healthy people 2000 objectives. Cancer. 2000; 89(3):696-705. DOI: 10.1002/1097-0142(20000801)89:3<696::aid-cncr27>3.0.co;2-7. View

Chavez L, Hubbell F, McMullin J, Martinez R, Mishra S . Structure and meaning in models of breast and cervical cancer risk factors: a comparison of perceptions among Latinas, Anglo women, and physicians. Med Anthropol Q. 1995; 9(1):40-74. DOI: 10.1525/maq.1995.9.1.02a00030. View

SCHWARZ P, Fasal E, Simmons M . 12-county program: screening of 34,318 women for cervical cancer in California, 1975-78. Public Health Rep. 1981; 96(6):547-54. PMC: 1424263. View

Michielutte R, Diseker R . Racial differences in knowledge of cancer: a pilot study. Soc Sci Med. 1982; 16(3):245-52. DOI: 10.1016/0277-9536(82)90335-5. View

Lane D . Compliance with referrals from a cancer-screening project. J Fam Pract. 1983; 17(5):811-7. View

Carmichael J, Jeffrey J, STEELE H, Ohlke I . The cytologic history of 245 patients developing invasive cervical carcinoma. Am J Obstet Gynecol. 1984; 148(5):685-90. DOI: 10.1016/0002-9378(84)90774-9. View

Michielutte R, Diseker R, Young L, May W . Noncompliance in screening follow-up among family planning clinic patients with cervical dysplasia. Prev Med. 1985; 14(2):248-58. DOI: 10.1016/0091-7435(85)90040-4. View

Koss L . The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA. 1989; 261(5):737-43. View

Paskett E, Carter W, Chu J, White E . Compliance behavior in women with abnormal Pap smears. Developing and testing a decision model. Med Care. 1990; 28(7):643-56. DOI: 10.1097/00005650-199007000-00009. View

10.

Paskett E, White E, Carter W, Chu J . Improving follow-up after an abnormal Pap smear: a randomized controlled trial. Prev Med. 1990; 19(6):630-41. DOI: 10.1016/0091-7435(90)90060-w. View

11.

Melnikow J, Chan B, STEWART G . Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?. Arch Fam Med. 1999; 8(6):510-4. DOI: 10.1001/archfami.8.6.510. View

12.

Tang T, Solomon L, Yeh C, Worden J . The role of cultural variables in breast self-examination and cervical cancer screening behavior in young Asian women living in the United States. J Behav Med. 1999; 22(5):419-36. DOI: 10.1023/a:1018653306776. View

13.

Janerich D, Hadjimichael O, Schwartz P, Lowell D, MEIGS J, Merino M . The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health. 1995; 85(6):791-4. PMC: 1615485. DOI: 10.2105/ajph.85.6.791. View

14.

Paskett E, Phillips K, Miller M . Improving compliance among women with abnormal Papanicolaou smears. Obstet Gynecol. 1995; 86(3):353-9. DOI: 10.1016/0029-7844(95)00176-R. View

15.

Tortolero-Luna G, Glober G, Villarreal R, Palos G, Linares A . Screening practices and knowledge, attitudes, and beliefs about cancer among Hispanic and non-Hispanic white women 35 years old or older in Nueces County, Texas. J Natl Cancer Inst Monogr. 1995; (18):49-56. View

16.

Morgan C, Park E, Cortes D . Beliefs, knowledge, and behavior about cancer among urban Hispanic women. J Natl Cancer Inst Monogr. 1995; (18):57-63. View

17.

Freda M, Runowicz C . "I hope I don't have cancer": colposcopy and minority women. Oncol Nurs Forum. 1996; 23(1):39-44. View

18.

Crane L . Social support and adherence behavior among women with abnormal Pap smears. J Cancer Educ. 1996; 11(3):164-73. DOI: 10.1080/08858199609528421. View

19.

Hubbell F, Chavez L, Mishra S, Valdez R . Beliefs about sexual behavior and other predictors of Papanicolaou smear screening among Latinas and Anglo women. Arch Intern Med. 1996; 156(20):2353-8. View

20.

Suarez L, Roche R, Nichols D, Simpson D . Knowledge, behavior, and fears concerning breast and cervical cancer among older low-income Mexican-American women. Am J Prev Med. 1997; 13(2):137-42. View